Organization: Health Canada
Year: 2020
Month: January
Request Number: A-2019-001176
Request Summary: Advise whether the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review on August 2017 has received either: a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W) or a NON-Withdrawal (NON-W).
Disposition: Disclosed in part
Number of pages: 5